In TUXEDO-2, ticagrelor failed to meet the bar for noninferiority, with most outcomes hinting at an advantage for prasugrel.

Researchers sought to determine the most appropriate P2Y12 inhibitor therapy in patients with acute coronary syndrome.

People with many different kinds of leukemias, including CLL (like your husband's), often have low platelet counts. However, ...

Do the blood thinners have anything to do with the low platelet count? The cardiologist recently reduced the Xarelto dosage ...

DES, adding clopidogrel in the chronic phase of coronary disease had no ischemic benefit and increased bleeding.

CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit ...

My husband was diagnosed with chronic lymphocytic leukemia (CLL) in 2010 and remained in stage 2 with no effects until 2022. In the interim, he was also diagnosed with atrial fibrillation and is ...

People with many different kinds of leukemias, including CLL (like your husband’s), often have low platelet counts. However, ...

After percutaneous coronary intervention (PCI), dual antiplatelet therapy (DAPT) is recommended for 6 months in stable ...

A 79-year-old man was admitted to a hospital in Guangzhou, China, with progressive dyspnea and edema. Echocardiography and ...

Dr Ray O’Connor contines his look at recent clinical articles on therapeutics, particlularly in the fields of cardiology, and ...